Quick answer: GLP-1 medicines are not recommended in pregnancy and are generally stopped well before trying to conceive. Separately, weight loss can restore ovulation in people who were not ovulating — particularly with PCOS — so pregnancy can occur unexpectedly. Contraception and a conception plan should be discussed before you start, not after.
The point most people are not warned about
If you have PCOS or obesity-related anovulation, losing weight can restore regular ovulation. That is a genuinely good outcome — and it means fertility can return before you expect it, sometimes while you assumed you could not conceive.
The 2023 international PCOS guideline places healthy lifestyle and weight management centrally in PCOS care precisely because of these downstream effects on cycles and fertility. If you have been told you would struggle to conceive, do not treat that as ongoing contraception once your weight starts changing.
Why these medicines are stopped before conception
GLP-1 receptor agonists are not recommended during pregnancy. Beyond the medication question, pregnancy is not a time for active weight loss — it is a time for adequate nutrition to support fetal development, which is fundamentally at odds with a treatment whose mechanism is appetite suppression.
Because these are long-acting drugs, clinicians generally advise stopping some weeks before trying to conceive. The specific interval depends on the medicine and is a conversation for your doctor rather than a number to take from an article.
Planning a pregnancy while on treatment
Raise it early — ideally months ahead. A sensible plan usually covers when to stop the medication, how to hold your weight steady in the gap rather than regaining rapidly, folic acid and other pre-conception nutrition, and reviewing any other medicines such as metformin or blood pressure drugs at the same time.
Weight regain after stopping is common — in the STEP 1 trial extension, participants regained roughly two-thirds of their lost weight within a year. Knowing that in advance lets you plan the maintenance phase deliberately instead of being surprised by it.
If you become pregnant unexpectedly
Contact your doctor promptly. Do not simply continue the medication, and equally, do not panic — this needs a clinical conversation, not an internet answer.
Breastfeeding and contraception
Use of these medicines while breastfeeding should be discussed with your clinician. On contraception, the practical point is that it needs to be in place and reliable if you are not planning a pregnancy, given fertility may return as weight falls.
The summary
Weight loss improving fertility is a benefit, not a complication — but only if it does not arrive as a surprise. Have the conversation about contraception and conception timing at the start of treatment, when it is a planning discussion rather than an urgent one.
Explore the topic
- GLP-1 weight loss in India
The complete guide to GLP-1 therapy, results and safety for Indian patients.
- Check your GLP-1 eligibility
Find out whether doctor-supervised GLP-1 therapy is clinically appropriate for you.
References
- Teede HJ et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction, 2023.
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022 — roughly two-thirds of lost weight regained one year after stopping.
This article is for general information and is not a substitute for individual medical advice. Prescription medicines referenced here are regulated in India by the Central Drugs Standard Control Organisation (CDSCO) and are dispensed only against a valid prescription from a registered medical practitioner.
Ready to Start Your Weight Loss Journey?
Get a personalized medical assessment from MetaFit's expert doctors — tailored for the Indian lifestyle.
Book a Free ConsultationOr download the app to get started



